Skip to main content
Log in

Level 5 Lymphadenopathy Warrants Heightened Suspicion for Clinically Significant Pathology

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

We conclude that patients presenting with level 5 lymphadenopathy should be investigated with heightened clinical vigilance. Our results suggest that up to 80 % will harbour clinically significant pathology requiring further medical treatment, three quarters of which will be malignancy. We report an observational study of histological outcomes of level 5 lymph node biopsies from a regional histopathology department across 5 years. 184 subjects were identified as having a biopsy of a lymph node from the level 5 region within the study period. One hundred and fifty six cases (84.8 %) had clinically significant pathology on final histology requiring further medical treatment. Lymphoma accounted for the highest number of cases (n = 72, 39.1 %), followed by metastatic carcinoma (n = 65, 35.3 %) and granulomatous change (n = 17, 9.2 %). Gender and laterality were not shown to be independent predictors of pathology significance (p > 0.05).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nolder AR. Paediatric cervical lymphadenopathy: when to biopsy? Curr Opin Otolaryngol Head Neck Surg. 2013;21(6):567–70.

    PubMed  Google Scholar 

  2. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician. 2002;66(11):2103–10.

    PubMed  Google Scholar 

  3. Gupta RK, Naran S, Lallu S, Fauck R. The diagnostic value of fine needle aspiration cytology (FNAC) in the assessment of palpable supraclavicular lymph nodes: a study of 218 cases. Cytopathology. 2003;14:201–7.

    Article  CAS  PubMed  Google Scholar 

  4. Robbins K, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536–8.

    Article  PubMed  Google Scholar 

  5. Genden E, Varvares M, editors. Head and neck cancer: an evidence-based team approach. New York: Thieme publishers; 2011. p. 181–97.

    Google Scholar 

  6. Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12:197–203.

    Article  CAS  PubMed  Google Scholar 

  7. McHenry CR, Cooney MM, Slusarczyk SJ, Khiyami A. Supraclavicular lymphadenopathy: the spectrum of pathology and evaluation by fine-needle aspiration biopsy. Am Surg. 1999;65(8):742–7.

    CAS  PubMed  Google Scholar 

  8. Ellison E, LaPuerta P, Martin SE. Supraclavicular masses: results of a series of 309 cases biopsied by fine needle aspiration. Head Neck. 1999;21(3):239–46.

    Article  CAS  PubMed  Google Scholar 

  9. Nasuti JF, Mehrotra R, Gupta PK. Diagnostic value of fine-needle aspiration in supraclavicular lymphadenopathy: a study of 106 patients and review of literature. Diagn Cytopathol. 2001;25(6):351–5.

    Article  CAS  PubMed  Google Scholar 

  10. Cervin JR, Silverman JF, Loggie BW, Geisinger KR. Virchow’s node revisited. Analysis with clinicopathologic correlation of 152 fine-needle aspiration biopsies of supraclavicular lymph nodes. Arch Path Lab Med. 1995;119(8):727–30.

    CAS  PubMed  Google Scholar 

  11. Ingolfsdottir M, Balle V, Hahn CH. Evaluation of cervical lymphadenopathy in children: advantages and drawbacks of diagnostic methods. Dan Med J. 2013;60(8):A4667.

    PubMed  Google Scholar 

  12. Oguz A, Karadeniz C, Temel EA, Citak EC, Okur FV. Evaluation of peripheral lymphadenopathy in children. Pediatr Haematol Oncol. 2006;23(7):549–61.

    Article  Google Scholar 

  13. Haematological Malignancy Research Network. Haematological malignancies cancer registration in England (2004–2008). Quality appraisal comparing data from the National Cancer Data Repository (NCDR) with the population-based Haematological Malignancy Research Network (HMRN). Final Report. London: Leukaemia & Lymphoma Research; 2012.

  14. Herd MK, Woods M, Anand R, Habib A, Brennan PA. Lymphoma presenting in the neck: current concepts in diagnosis. Br J Oral Maxillofac Surg. 2012;50(4):309–13.

    Article  CAS  PubMed  Google Scholar 

  15. Pedersen OM, Aarstad HJ, Løkeland T, Bostad L. Diagnostic yield of biopsies of cervical lymph nodes using a large (14-gauge) core biopsy needle. APMIS. 2013;121:1119–30.

    Article  PubMed  Google Scholar 

  16. British Committee for Standards in Haematology. Best practice in lymphoma diagnosis and reporting. Royal College of Pathologists. London 2010. http://www.bcshguidelines.com/documents/Lymphoma_diagnosis_bcsh_042010.pdf.

  17. Robertson EG, Baxter G. Tumour seeding following percutaneous needle biopsy: the real story! Clin Radiol. 2011;66(11):1007–14.

    Article  CAS  PubMed  Google Scholar 

  18. Cheung L, McCombe A. The diagnostic yield of cervical lymph node excision biopsy presenting via the head and neck ‘lump-and-bump’ clinic. Clin Otolaryngol. 2014;39:133.

    Article  CAS  PubMed  Google Scholar 

  19. Battista AF. Complications of biopsy of the cervical lymph node. Surg Gynecol Obstet. 1991;173:142–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Cunnane.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cunnane, M., Cheung, L., Moore, A. et al. Level 5 Lymphadenopathy Warrants Heightened Suspicion for Clinically Significant Pathology. Head and Neck Pathol 10, 509–512 (2016). https://doi.org/10.1007/s12105-016-0733-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-016-0733-6

Keywords

Navigation